Inhibition of oligodendrocyte precursor cell differentiation by myelin-associated proteins

Neurosurgical Focus

Volumn 24, Issue 3-4, 2008, Pages

  Syed, Yasir A ^a   Baer, Alexandra S ^a   Lubec, Gert ^a   Hoeger, Harald ^a   Widhalm, Georg ^a   Kotter, Mark R ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Myelin inhibition; Precursor cell; Regeneration; Remyelination; Stem cell

Indexed keywords

HOMEODOMAIN PROTEIN; MYELIN BASIC PROTEIN; NKX 2.2 HOMEDOMAIN PROTEIN; NKX-2.2 HOMEDOMAIN PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CHO CELL; CRICETULUS; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FOREBRAIN; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HAMSTER; METABOLISM; METHODOLOGY; NERVE FIBER; NEWBORN; OLIGODENDROGLIA; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; STEM CELL;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; AXONS; CELL DIFFERENTIATION; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; MYELIN BASIC PROTEINS; OLIGODENDROGLIA; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 42149161906     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/FOC/2008/24/3-4/E3     Document Type: Article

References (61)

1. Aveldaño MI, Díaz RS, Regueiro P, Monreal J: Solubilization of myelin membranes by detergents. J Neurochem 57:250-257, 1991
2. Bambakidis NC, Miller RH: Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J 4:16-26, 2004
3. Bartzokis G: Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25:5-18, 2004
4. Beattie MS, Harrington AW, Lee R, Kim JY, Boyce SL, Longo FM, et al: ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36:375-386, 2002
5. Blakemore WF: Pattern of remyelination in the CNS. Nature 249:577-578, 1974
6. Cai D, Deng & Mellado W, Lee J, Ratan RR, Filbin MT: Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron 35:711-719, 2002
7. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD: NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404-6412, 2000
8. Chang A, Tourtellotte WW, Rudick R., Trapp BD: Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173, 2002
9. Chen MS, Huber AB, van der Ham ME, Frank M, Schnell L, Spillmann AA, et al: Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403:434-439, 2000
10. Compston A, Coles A: Multiple sclerosis. Lancet 359:1221-1231, 2002
11. Dewar D, Underhill SM, Goldberg MP: Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab 23:263-274, 2003
12. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, et al: Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35:283-290, 2002
13. Dong H, Fazzaro A, Xiang C, Korsmeyer SJ, Jacquin MF, McDonald JW: Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration. J Neurosci 23:8682-8691, 2003
14. Dowling P, Ming X, Raval S, Husar W, Casaccia-Bonnefil P, Chao M, et al: Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques. Neurology 53:1676-1682, 1999
15. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler a Montague P, et al: Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166:121-131, 2004
16. Fancy SP, Zhao C, Franklin RJ: Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27:247-254, 2004
17. Ferguson B, Matyszak MK, Esiri MM, Perry VH: Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399, 1997
18. Filbin MT: Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 4:703-713, 2003
19. Fournier AE, GrandPre T, Strittmatter SM: Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409:341-346, 2001
20. Franklin RJ: Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714, 2002
21. Franklin RJ, Blakemore WF: Transplanting oligodendrocyte progenitors into the adult CNS. J Anat 190:23-33, 1997
22. GrandPré T, Nakamura F, Vartanian T, Strittmatter SM: Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403:439-444, 2000
23. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, et al: Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613, 1998
24. Hemmer B, Archelos JJ, Hartung HP: New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3: 291-301, 2002
25. Hof PR, Haroutunian V, Friedrich VL Jr, Byne W, Buitron C, Perl DP, et al: Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53:1075-1085, 2003
26. Jeffery ND, Blakemore WF: Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120:27-37, 1997
27. Kotter MP, Li WW, Zhao C, Franklin RJ: Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26:328-332, 2006
28. Kottis V, Thibault P, Mikol D, Xiao ZC, Zhang R, Dergham. P, et al: Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem 82:1566-1569, 2002
29. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E. Lee J, Braun PE, et al: Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374, 2003
30. Lassmann H, Bruck W, Lucchinetti C: Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7:115-121, 2001
31. Lee KH, Yoon DH, Park YG, Lee BH: Effects of glial transplantation on functional recovery following acute spinal cord injury. J Neurotrauma 22:575-589, 2005
32. Liu BP, Fournier A, GrandPré T, Strittmatter SM: Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297:1190-1193, 2002
33. Lovas G, Szilágyi N, Majtényi K, Palkovits M, Komoly S: Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123:308-317, 2000
34. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47: 707-717, 2000
35. Mandai K, Matsumoto M, Kitagawa K, Matsushita K, Ohtsuki T, Mabuchi T, et al: Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience 77:849-861, 1997
36. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902, 1980
37. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE: Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13:805-811, 1994
38. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, et al: LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7:221-228, 2004
39. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, et al: LINGO-1 negatively regulates myelination by oligodenrocytes. Nat Neurosci 8:745-751, 2005
40. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT: A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13:757-767, 1994
41. Noble M: The possible role of myelin destruction as a precipitating event in Alzheimer's disease. Neurobiol Aging 25:25-31, 2004
42. Norton WT, Poduslo SE: Myelination in rat brain: method of myelin isolation. J Neurochem 21:749-757, 1973
43. Oertle T, van der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A, et al: Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 23:5393-5406, 2003
44. Petratos S, Gonzales MF, Azari MF, Marriott M, Minichiello RA, Shipham KA, et al: Expression of the low-affinity neurotrophin receptor, p75(NTR), is upregulated by oligodendroglial progenitors adjacent to the subventricular zone in response to demyelination. Glia 48:64-75, 2004
45. Qi Y, Cai J, Wu Y, Wu R, Lee J, Fu H, et al: Control of oligodendrocyte differentiation by the Nkx2.2-homeodomain transcription factor. Development 128:2723-2733, 2001
46. Robinson S, Miller RH: Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev Biol 216:359-368, 1999
47. Schweigreiter R, Walmsley AR, Niederost B, Zimmermann DR, Oertle T, Casademunt E, et al: Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growdi via p75NTR/NgR-independent pathways that converge at RhoA. Mol Cell Neurosci 27:163-174, 2004
48. Smith EJ, Blakemore WF, McDonald WI: Central remyelination restores secure conduction. Nature 280:395-396, 1979
49. Song XY, Zhong JH, Wang Y, Zhou XF: Suppression of p75NTR does not promote regeneration of injured spinal cord in mice. J Neurosci 24:542-546, 2004
50. Stirling DP, Khodarahmi Y, Liu J, McPhail LT, McBride CB, Steeves JD, et al: Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 24: 2182-2190, 2004
51. Tamura M, Nakamura M, Ogawa Y, Toyama Y, Miura M, Okano H: Targeted expression of anti-apoptotic protein p35 in oligodendrocytes reduces delayed demyelination and functional impairment after spinal cord injury. Glia 51:312-321, 2005
52. Taylor CM, Marta CB, Claycomb RJ, Han DK, Rasband MN, Coetzee T, et al: Proteomic mapping provides powerful insights into functional myelin biology. Proc Natl Acad Sci U S A 101: 4643-4648, 2004
53. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, et al: Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362:798-805, 2003
54. Totoiu MO, Keirstead HS: Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 486:373-383, 2005
55. Vanrobaeys F, Van Coster R, Dhondt G, Devreese B, Van Beeumen J: Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry. J Proteome Res 4:2283-2293, 2005
56. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z: P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420:74-78, 2002
57. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, et al: Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417:941-944, 2002
58. Wolswijk G: Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601-609, 1998
59. Wong ST, Henley JR, Kanning KC, Huang KH, Bothwell M, Poo MM: A: p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 5:1302-1308, 2002
60. Yamashita T, Higuchi H, Tohyama M: The p75 receptor transduces the signal frona myelin-associated glycoprotein to Rho. J Cell Biol 157:565-570, 2002
61. Zheng B, Atwal J, Ho C, Case L, He XL, Garcia KC, et al: Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc Natl Acad Sci U S A 102:1205-1210, 2005